AKT1 and type 1 diabetes mellitus: Compared with other PI3K/AKT pathway regulators, FhHDM-1 not only enhanced the function of pancreatic β-cells and prevented apoptosis but also inhibited carcinogenesis caused by excessive proliferation of pancreatic β-cells, which had significant advantages in treating type 1 diabetes in mice[83].